William Grossman, Interim Chief Medical Officer, Director at enGene Holdings, holds 5.10K shares in enGene Holdings (Ticker: ENGN), holds 20.72K shares in Arcus Biosciences (Ticker: RCUS), holds 26.87K shares in Bellicum Pharmaceuticals (Ticker: BLCM). Most recently, William Grossman Bought ― shares of enGene Holdings on Sep 24, 2026 for an estimated value of $10.05K.
What is the percentage of profitable transactions made by William Grossman?
The percentage of profitable transactions made by William Grossman is 40%.
What is the average return per transaction made by William Grossman?
The average return per transaction made by William Grossman is 39.90%.
What stocks does William Grossman hold?
William Grossman holds: ENGN, BLCM, RCUS, DAWN stocks.
What was William Grossman’s latest transaction?
William Grossman latest transaction was an Informative Buy of $10.05K.
What was William Grossman's most profitable transaction?
William Grossman’s most profitable transaction was an Informative Buy of RCUS stock on October 15, 2019. The return on the trade was 152.20%.
What is William Grossman's role in enGene Holdings?
William Grossman's role in enGene Holdings is Interim Chief Medical Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.